<DOC>
	<DOCNO>NCT00002099</DOCNO>
	<brief_summary>To determine tolerance side effect combination lentinan didanosine ( ddI ) comparison ddI alone . To determine whether combination lentinan ddI produce significant immunorestorative effect within study observation period ( 6-12 month ) measure increase one follow : neutrophil count activity , T-cell subset , decrease p24 antigen .</brief_summary>
	<brief_title>Phase II/III Study Tolerance Efficacy Combined Use Didanosine ( 2',3'-Dideoxyinosine ; ddI ) Lentinan HIV-Positive Patients</brief_title>
	<detailed_description>Patients treat daily oral ddI 6 week , randomize ddI combination intravenous lentinan placebo ( administered weekly ) 26 week . Patients already stabilize 400 mg/day ddI proceed directly randomization . Following completion combination therapy , patient may offer 26 additional week therapy optional basis .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Lentinan</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV seropositivity . Absolute CD4 count 200 500 cells/mm3 . No active opportunistic infection Kaposi 's sarcoma . Prior Medication : Allowed : Prior ddI longer 3 month . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Lymphoid malignancy . Pancreatitis . Peripheral neuropathy . Critical illness . Concurrent Medication : Excluded : Antiretroviral agent ddI . Steroids . Cytotoxic agent . Immunosuppressive agent . Immunomodulators . 1Thyroxine . Concurrent Treatment : Excluded : Radiotherapy . Prior Medication : Excluded within 1 month prior study entry : Antiretroviral agent ddI ( patient may receive prior ddI longer 3 month total ) . Steroids . Cytotoxic agent . Immunosuppressive agent . Immunomodulators . Prior Treatment : Excluded : Radiotherapy within 1 month prior study entry . Active IV drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 1994</verification_date>
	<keyword>Didanosine</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Lentinan</keyword>
</DOC>